News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Advts:
Classifieds |
Employment |
Obituary |
Business
Mankind Pharma to invest Rs. 70 cr.
Staff Correspondent
CHENNAI:
The Delhi-based Mankind Pharma Pvt. Ltd plans to invest Rs. 70 crore in the next two years to scale up its manufacturing capability and invest in research and development (R&D).
Addressing a press conference here on Tuesday, R. C. Juneja, Managing Director, Mankind Pharma, said the new manufacturing plant, complying with the U.S. Food and Drug Administration standards, was being set up in Poanta Sahib, Himachal Pradesh. It would set up a latest R&D facility in the National Capital Region (NCR). The company was planning to export its products to other semi-regulated markets of Southeast Asia, South Africa and some CIS (Commonwealth of Independent States) countries, said Rajiv Juneja, Director, Marketing.
"Currently, we have a 1,900 strong field force. Over the next two years, this number was likely to grow to 3,000," he added.
Printer friendly
page
Send this article to Friends by
E-Mail
Business
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Advts:
Classifieds |
Employment |
Obituary |
Updates:
Breaking News |
|
